These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35201477)

  • 1. Post-neonatal Outcomes of Infants Born to Women with Active Trimester One Inflammatory Bowel Disease: A Pilot Study.
    Wu RY; Tandon P; Ambrosio L; Dunsmore G; Hotte N; Dieleman LA; Elahi S; Madsen K; Huang V
    Dig Dis Sci; 2022 Nov; 67(11):5177-5186. PubMed ID: 35201477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry.
    Odufalu FD; Long M; Lin K; Mahadevan U;
    Gut; 2022 Sep; 71(9):1766-1772. PubMed ID: 34686575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Active IBD During Pregnancy in the Era of Novel IBD Therapies.
    de Lima-Karagiannis A; Zelinkova-Detkova Z; van der Woude CJ
    Am J Gastroenterol; 2016 Sep; 111(9):1305-12. PubMed ID: 27349339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease in pregnancy: a population-based study of prevalence and pregnancy outcomes.
    Shand AW; Chen JS; Selby W; Solomon M; Roberts CL
    BJOG; 2016 Oct; 123(11):1862-70. PubMed ID: 26924786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Despite Increased Disease Activity, Women who Attended a Dedicated Inflammatory Bowel Disease and Pregnancy Clinic Had Infants With Higher Apgar Scores: A Population-Based Study.
    Lee S; Seow CH; Nerenberg K; Bertazzon S; Leung Y; Huang V; Whitten T; Coward S; Panaccione R; Kaplan GG; Metcalfe A
    Inflamm Bowel Dis; 2024 Jul; 30(7):1071-1079. PubMed ID: 37499061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.
    Dominitz JA; Young JC; Boyko EJ
    Am J Gastroenterol; 2002 Mar; 97(3):641-8. PubMed ID: 11926208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy outcomes in women with inflammatory bowel disease who successfully conceived via assisted reproduction technique.
    Lavie I; Lavie M; Doyev R; Fouks Y; Azem F; Yogev Y
    Arch Gynecol Obstet; 2020 Sep; 302(3):611-618. PubMed ID: 32529298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study.
    Kanis SL; de Lima-Karagiannis A; de Boer NKH; van der Woude CJ
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1232-1241.e1. PubMed ID: 28342949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of azathioprine and corticosteroids during pregnancy and birth outcome in women diagnosed with inflammatory bowel disease.
    Plauborg AV; Hansen AV; Garne E
    Birth Defects Res A Clin Mol Teratol; 2016 Jun; 106(6):494-9. PubMed ID: 27301563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory bowel disease and new-onset psychiatric disorders in pregnancy and post partum: a population-based cohort study.
    Vigod SN; Kurdyak P; Brown HK; Nguyen GC; Targownik LE; Seow CH; Kuenzig ME; Benchimol EI
    Gut; 2019 Sep; 68(9):1597-1605. PubMed ID: 30630948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcomes in women with inflammatory bowel disease: a 10-year nationwide population-based cohort study.
    Lee HH; Bae JM; Lee BI; Lee KM; Wie JH; Kim JS; Cho YS; Jung SA; Kim SW; Choi H; Choi MG
    Aliment Pharmacol Ther; 2020 May; 51(9):861-869. PubMed ID: 32266739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal Calprotectin May Predict Adverse Pregnancy-Related Outcomes in Patients with Inflammatory Bowel Disease.
    Tandon P; Lee EY; Maxwell C; Hitz L; Ambrosio L; Dieleman L; Halloran B; Kroeker K; Huang VM
    Dig Dis Sci; 2021 May; 66(5):1639-1649. PubMed ID: 32533542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy-Onset Inflammatory Bowel Disease: A Subtle Diagnosis.
    Koslowsky B; Grisaru-Granovsky S; Livovsky DM; Milgrom Y; Goldin E; Bar-Gil Shitrit A
    Inflamm Bowel Dis; 2018 Jul; 24(8):1826-1832. PubMed ID: 29788306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time to Diagnosis and Birth Outcomes of Pregnancy-onset IBD.
    Vestergaard T; Røsok J; Julsgaard M; Bek Helmig R; Friedman S; Kelsen J
    Inflamm Bowel Dis; 2024 Feb; 30(2):222-229. PubMed ID: 37075485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregnancy with inflammatory bowel disease: Outcomes for mothers and their children at a European tertiary care center.
    Hoffmann P; Krueger J; Bashlekova T; Rupp C; Baumann L; Gauss A
    J Obstet Gynaecol Res; 2022 Mar; 48(3):621-633. PubMed ID: 34935257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
    Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
    Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease flare at prior pregnancy and disease activity at conception are important determinants of disease relapse at subsequent pregnancy in women with inflammatory bowel diseases.
    Rottenstreich A; Fridman Lev S; Rotem R; Mishael T; Grisaru Granovsky S; Koslowsky B; Goldin E; Bar-Gil Shitrit A
    Arch Gynecol Obstet; 2020 Jun; 301(6):1449-1454. PubMed ID: 32377786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Leung KK; Tandon P; Govardhanam V; Maxwell C; Huang V
    Inflamm Bowel Dis; 2021 Mar; 27(4):550-562. PubMed ID: 32469057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease and Pregnancy: Is It a Marker for Adverse Outcomes?
    Costa RV; Simões C; Correia L; Pinto L
    Rev Bras Ginecol Obstet; 2022 Oct; 44(10):915-924. PubMed ID: 36446558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.